FDA Inspection 1279979 — Biowy Corporation

Biowy Corporation — FEI 3013233645

The FDA completed an inspection of Biowy Corporation on Aug 8, 2025 in Lake Forest, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 8, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lake Forest, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.